These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 6761909

  • 1. Viral haemorrhagic fever antibodies in Zimbabwe schoolchildren.
    Blackburn NK, Searle L, Taylor P.
    Trans R Soc Trop Med Hyg; 1982; 76(6):803-5. PubMed ID: 6761909
    [No Abstract] [Full Text] [Related]

  • 2. Antibodies to haemorrhagic fever viruses in Madagascar populations.
    Mathiot CC, Fontenille D, Georges AJ, Coulanges P.
    Trans R Soc Trop Med Hyg; 1989; 83(3):407-9. PubMed ID: 2515626
    [Abstract] [Full Text] [Related]

  • 3. Antibodies against haemorrhagic fever viruses in Kenya populations.
    Johnson BK, Ocheng D, Gichogo A, Okiro M, Libondo D, Tukei PM, Ho M, Mugambi M, Timms GL, French M.
    Trans R Soc Trop Med Hyg; 1983; 77(5):731-3. PubMed ID: 6419422
    [Abstract] [Full Text] [Related]

  • 4. [Method for the simultaneous detection of immunofluorescing antibodies to the causative agents of different hemorrhagic fevers].
    Lukashevich IS, van der Groen G.
    Vopr Virusol; 1985; 30(5):624-6. PubMed ID: 3907144
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa.
    Van der Waals FW, Pomeroy KL, Goudsmit J, Asher DM, Gajdusek DC.
    Trop Geogr Med; 1986 Sep; 38(3):209-14. PubMed ID: 3092415
    [Abstract] [Full Text] [Related]

  • 7. Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys.
    Johnson KM, Elliott LH, Heymann DL.
    J Clin Microbiol; 1981 Nov; 14(5):527-9. PubMed ID: 7031084
    [Abstract] [Full Text] [Related]

  • 8. Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations.
    Gonzalez JP, Josse R, Johnson ED, Merlin M, Georges AJ, Abandja J, Danyod M, Delaporte E, Dupont A, Ghogomu A.
    Res Virol; 1989 Nov; 140(4):319-31. PubMed ID: 2505350
    [Abstract] [Full Text] [Related]

  • 9. The Role of Reference Materials in the Research and Development of Diagnostic Tools and Treatments for Haemorrhagic Fever Viruses.
    Mattiuzzo G, Bentley EM, Page M.
    Viruses; 2019 Aug 24; 11(9):. PubMed ID: 31450611
    [Abstract] [Full Text] [Related]

  • 10. Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué.
    Ivanoff B, Duquesnoy P, Languillat G, Saluzzo JF, Georges A, Gonzalez JP, McCormick J.
    Trans R Soc Trop Med Hyg; 1982 Aug 24; 76(6):719-20. PubMed ID: 7164137
    [Abstract] [Full Text] [Related]

  • 11. [Sero-epidemiological study in Mauritania (1985-1986): incidence of treponematosis, hepatitis B virus, HIV virus and viral hemorrhagic fevers].
    Lepers JP, Billon C, Pesce JL, Rollin PE, De Saint-Martin J.
    Bull Soc Pathol Exot Filiales; 1988 Aug 24; 81(1):24-31. PubMed ID: 2900081
    [Abstract] [Full Text] [Related]

  • 12. [Microbiological surveillance: viral hemorrhagic fever in Central African Republic: current serological data in man].
    Nakounné E, Selekon B, Morvan J.
    Bull Soc Pathol Exot; 2000 Jan 24; 93(5):340-7. PubMed ID: 11775321
    [Abstract] [Full Text] [Related]

  • 13. Marburg, Ebola and Rift Valley Fever virus antibodies in East African primates.
    Johnson BK, Gitau LG, Gichogo A, Tukei PM, Else JG, Suleman MA, Kimani R, Sayer PD.
    Trans R Soc Trop Med Hyg; 1982 Jan 24; 76(3):307-10. PubMed ID: 6810518
    [Abstract] [Full Text] [Related]

  • 14. Use of betapropionolactone inactivated Ebola, Marburg and Lassa intracellular antigens in immunofluorescent antibody assay.
    Van der Groen G, Elliot LH.
    Ann Soc Belg Med Trop; 1982 Mar 24; 62(1):49-54. PubMed ID: 7049096
    [No Abstract] [Full Text] [Related]

  • 15. Viral haemorrhagic fever surveillance in Kenya, 1980-1981.
    Johnson BK, Ocheng D, Gitau LG, Gichogo A, Tukei PM, Ngindu A, Langatt A, Smith DH, Johnson KM, Kiley MP, Swanepoel R, Isaacson M.
    Trop Geogr Med; 1983 Mar 24; 35(1):43-7. PubMed ID: 6684336
    [Abstract] [Full Text] [Related]

  • 16. [Serological study of the virus responsible for hemorrhagic fever in an urban population of Cameroon].
    Paix MA, Poveda JD, Malvy D, Bailly C, Merlin M, Fleury HJ.
    Bull Soc Pathol Exot Filiales; 1988 Mar 24; 81(4):679-82. PubMed ID: 3064937
    [Abstract] [Full Text] [Related]

  • 17. Seroprevalence of Alkhurma and other hemorrhagic fever viruses, Saudi Arabia.
    Memish ZA, Albarrak A, Almazroa MA, Al-Omar I, Alhakeem R, Assiri A, Fagbo S, MacNeil A, Rollin PE, Abdullah N, Stephens G.
    Emerg Infect Dis; 2011 Dec 24; 17(12):2316-8. PubMed ID: 22172587
    [Abstract] [Full Text] [Related]

  • 18. Recent advances in vaccines against viral haemorrhagic fevers.
    Baize S, Marianneau P, Georges-Courbot MC, Deubel V.
    Curr Opin Infect Dis; 2001 Oct 24; 14(5):513-8. PubMed ID: 11964870
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.